Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Sun Pharmaceutical Industries    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES

(SUNPHARMA)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
02/12/2019 02/13/2019 02/14/2019 02/15/2019 02/18/2019 Date
436.6(c) 431.25(c) 440.9(c) 422.9(c) 414.65 Last
8 559 968 31 434 625 9 040 227 10 206 627 6 210 412 Volume
+1.88% -1.23% +2.24% -4.08% -1.95% Change
More quotes
Financials (INR)
Sales 2019 295 B
EBIT 2019 50 803 M
Net income 2019 34 794 M
Finance 2019 50 649 M
Yield 2019 0,60%
Sales 2020 333 B
EBIT 2020 62 827 M
Net income 2020 51 710 M
Finance 2020 76 865 M
Yield 2020 0,75%
P/E ratio 2019 28,19
P/E ratio 2020 19,76
EV / Sales2019 3,27x
EV / Sales2020 2,82x
Capitalization 1 015 B
More Financials
Company
Sun Pharmaceutical Industries is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (98.4%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - active... 
Sector
Pharmaceuticals
Calendar
05/29Earnings Release
More about the company
Surperformance© ratings of Sun Pharmaceutical Industr
Trading Rating : Investor Rating :
More Ratings
Latest news on SUN PHARMACEUTICAL INDUSTR
02/13SUN PHARMACEUTICAL INDUSTRIES : Pharma responds to SEBI queries; posts 1,242-cr ..
AQ
02/13SUN PHARMACEUTICAL INDUSTRIES : Pharma reports Q3FY19 results
AQ
02/13SUN PHARMACEUTICAL INDUSTRIES : Pharma reports 49% jump in net profit at Rs 1,24..
AQ
01/29SUN PHARMACEUTICAL INDUSTRIES : Pharma Q3 FY19 financial result on 12 February 2..
AQ
01/24SUN PHARMA ADVANCED RESEARCH : changes distributor, gains 5%
AQ
01/23SUN PHARMACEUTICAL INDUSTRIES : Pharma - Investor Update
AQ
01/21GLENMARK PHARMACEUTICALS : Lupin, Sun Pharma, Glenmark recall products in US
AQ
01/18SUN PHARMACEUTICAL INDUSTRIES : India's Sun Pharma asks regulator to examine med..
RE
01/18SUN PHARMACEUTICAL INDUSTRIES : India's Sun Pharma tumbles on reports of fresh w..
RE
01/16SUN PHARMACEUTICAL INDUSTRIES : Ferring Pharmaceuticals adds two products to its..
AQ
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTR
More recommendations
Sector news : Generic Pharmaceuticals
02/17Cash-hoarding Japanese firms please investors as share buybacks hit record
RE
02/15BRISTOL MYERS SQUIBB : Starboard gauges Bristol-Myers shareholder support for Ce..
RE
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -2-
DJ
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -- Journal Report
DJ
More sector news : Generic Pharmaceuticals
Chart SUN PHARMACEUTICAL INDUSTRIES
Duration : Period :
Sun Pharmaceutical Industries Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTR
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 36
Average target price 511  INR
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Dilip Shantilal Shanghvi Managing Director & Executive Director
Israel Makov Non-Executive Chairman
C. S. Muralidharan Chief Financial Officer
Sudhir Vrundavandas Valia Executive Director
Sailesh Trambaklal Desai Executive Director
Sector and Competitors